Key Points
- Director Thomas Bohjalian bought 10,000 shares at an average price of $18.09 on March 6, spending $180,900 and boosting his stake to 85,520 shares (a 13.24% increase), as disclosed in an SEC filing.
- Healthcare Realty reported a quarterly EPS of $0.04, missing the $0.40 estimate, with revenue down 7.6% year-over-year, a negative net margin of 20.84%, and FY2026 guidance of 1.58–1.64 EPS (consensus ~1.59).
- The company declared a quarterly dividend of $0.24 (annualized $0.96) yielding 5.2% with an ex-dividend date of Feb 24, although its dividend payout ratio is currently negative at -135.21%.
Healthcare Realty Trust Incorporated (NYSE:HR - Get Free Report) Director Thomas Bohjalian bought 10,000 shares of the business's stock in a transaction that occurred on Friday, March 6th. The shares were acquired at an average price of $18.09 per share, for a total transaction of $180,900.00. Following the completion of the transaction, the director owned 85,520 shares in the company, valued at $1,547,056.80. This trade represents a 13.24% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Healthcare Realty Trust Trading Down 0.1%
HR traded down $0.01 during trading on Friday, reaching $18.38. 2,198,144 shares of the company's stock were exchanged, compared to its average volume of 4,298,567. Healthcare Realty Trust Incorporated has a one year low of $14.09 and a one year high of $18.97. The firm has a fifty day moving average price of $17.44 and a two-hundred day moving average price of $17.66. The stock has a market capitalization of $6.41 billion, a PE ratio of -25.89 and a beta of 0.96.
Healthcare Realty Trust (NYSE:HR - Get Free Report) last released its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by ($0.36). The business had revenue of $282.69 million for the quarter, compared to the consensus estimate of $284.37 million. Healthcare Realty Trust had a negative net margin of 20.84% and a negative return on equity of 5.07%. Healthcare Realty Trust's revenue was down 7.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.40 EPS. Healthcare Realty Trust has set its FY 2026 guidance at 1.580-1.640 EPS. Sell-side analysts expect that Healthcare Realty Trust Incorporated will post 1.59 earnings per share for the current year.
Healthcare Realty Trust Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 11th. Investors of record on Tuesday, February 24th will be given a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 5.2%. The ex-dividend date of this dividend is Tuesday, February 24th. Healthcare Realty Trust's dividend payout ratio (DPR) is currently -135.21%.
Analysts Set New Price Targets
A number of equities research analysts have commented on the company. Cantor Fitzgerald upped their price target on Healthcare Realty Trust from $19.00 to $21.00 and gave the company an "overweight" rating in a research report on Tuesday, February 17th. Wells Fargo & Company upped their target price on Healthcare Realty Trust from $18.00 to $19.00 and gave the company an "equal weight" rating in a report on Tuesday, November 25th. Weiss Ratings restated a "hold (c)" rating on shares of Healthcare Realty Trust in a report on Monday, December 29th. Citigroup upped their price objective on shares of Healthcare Realty Trust from $17.00 to $19.00 and gave the company a "neutral" rating in a research note on Wednesday, November 12th. Finally, Wall Street Zen upgraded shares of Healthcare Realty Trust from a "sell" rating to a "hold" rating in a research report on Saturday, January 31st. Three analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Healthcare Realty Trust has an average rating of "Hold" and an average target price of $18.88.
Get Our Latest Research Report on HR
Institutional Investors Weigh In On Healthcare Realty Trust
Several institutional investors and hedge funds have recently made changes to their positions in the business. Wiser Advisor Group LLC acquired a new stake in Healthcare Realty Trust during the third quarter worth approximately $25,000. Smartleaf Asset Management LLC boosted its holdings in shares of Healthcare Realty Trust by 179.7% during the 3rd quarter. Smartleaf Asset Management LLC now owns 1,608 shares of the real estate investment trust's stock worth $29,000 after buying an additional 1,033 shares in the last quarter. Atlantic Union Bankshares Corp bought a new position in Healthcare Realty Trust in the third quarter worth approximately $32,000. Eurizon Capital SGR S.p.A. acquired a new stake in Healthcare Realty Trust in the fourth quarter valued at approximately $37,000. Finally, Prosperity Bancshares Inc acquired a new stake in Healthcare Realty Trust in the fourth quarter valued at approximately $42,000.
About Healthcare Realty Trust
(
Get Free Report)
Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company's portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.
The company's properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
